<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03737838</url>
  </required_header>
  <id_info>
    <org_study_id>IRB17-1769</org_study_id>
    <nct_id>NCT03737838</nct_id>
  </id_info>
  <brief_title>Propagation ANalysis for Arrhythmogenic Conduction Elimination to Prevent Atrial Flutter and Fibrillation (PANACEA-AF)</brief_title>
  <acronym>PANACEA-AF</acronym>
  <official_title>Propagation ANalysis for Arrhythmogenic Conduction Elimination to Prevent Atrial Flutter and Fibrillation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Chicago</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Chicago</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to perform ultra-high density mapping of the left atrium (a
      chamber of the heart) using the the Rhythmia Mapping System and to determine whether
      additional ablation in areas of wavefront discontinuities identified by the map will reduce
      the likelihood of both atrial fibrillation and atrial flutter.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Catheter ablation (CA) is a class 1 indication for patients with symptomatic drug-refractory
      atrial fibrillation (AF). With standard pulmonary vein isolation (PVI), the success rate
      ranges from 60-80% in patients with paroxysmal AF. Despite PVI, certain patients have
      recurrent AF and often require a repeat ablation procedure.

      There is no standard ablation strategy for patients who undergo repeat ablation for recurrent
      AF. The largest randomized trial to date comparing ablation strategies found that the
      addition of LA roof and mitral isthmus ablation lines or ablation of LA ganglia was no better
      than standard PVI. Moreover, the addition of ablation lines in the LA, if not complete, may
      be pro-arrhythmic and lead to the development of LA AFL, which is often more symptomatic that
      AF itself.

      Ultra-high density mapping during sinus rhythm allows for rapid creation of isochronal late
      activation maps (ILAM) in patients with ventricular tachycardia. To date, creating ILAM of
      the LA has not been reported and it is not known whether additional ablation in these areas
      improves freedom from all atrial tachyarrhythmias at 1 year follow-up. Moreover, ablation at
      the deceleration zones and/or gaps identified using ultra-high density mapping is a promising
      strategy to improve ablation success and decrease the potential for recurrent AF.

      The rationale of the study is two-fold.

        1. This study would be the first to report ILAM in the LA and confirm that the diseased LA
           may behave similarly to the diseased left or right ventricle.

        2. Ablation of gaps and/or deceleration zones in the LA would be a novel approach to treat
           patients with recurrent AF after initial PVI, and if successful, provide another
           strategy to treat these refractory problems.

      Co-PIs:

      Hemal Nayak, MD Guarav Upadhyay, MD Andrew Beaser, MD Zaid Aziz, MD
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 31, 2018</start_date>
  <completion_date type="Anticipated">November 2020</completion_date>
  <primary_completion_date type="Anticipated">November 2020</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>12 Months</target_duration>
  <primary_outcome>
    <measure>Freedom from recurrent atrial fibrillation and atrial flutter</measure>
    <time_frame>Baseline to 1 year</time_frame>
    <description>Freedom from atrial arrhythmias</description>
  </primary_outcome>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Atrial Fibrillation</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Atrial fibrillation ablation</intervention_name>
    <description>High density mapping of left atrium using Rhythmia mapping system to identify gaps in conduction and wavefront discontinuities (deceleration zones)</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Prospective cohort of patients with AF refractory to prior ablation
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients at least 18 years of age

          -  Re-do AF ablation with history of PVI

          -  Undergone at least 1 prior ablation

        Exclusion Criteria:

          -  Inability of patient capacity to provide consent for themselves either due to medical
             or psychiatric comorbidity

          -  Recent stroke within 6 months of planned procedure

          -  Inability to take oral anticoagulation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Roderick Tung</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Chicago</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Tiffany Hart</last_name>
    <phone>773-702-0535</phone>
    <email>thart@medicine.bsd.uchicago.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>The University of Chicago</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60637</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tiffany Hart</last_name>
      <phone>773-702-0535</phone>
      <email>thart@medicine.bsd.uchicago.edu</email>
    </contact>
    <contact_backup>
      <last_name>Roderick Tung, MD</last_name>
      <phone>773-834-0455</phone>
      <email>rtung1@medicine.bsd.uchicago.edu</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Anter E, Tschabrunn CM, Buxton AE, Josephson ME. High-Resolution Mapping of Postinfarction Reentrant Ventricular Tachycardia: Electrophysiological Characterization of the Circuit. Circulation. 2016 Jul 26;134(4):314-27. doi: 10.1161/CIRCULATIONAHA.116.021955.</citation>
    <PMID>27440005</PMID>
  </reference>
  <reference>
    <citation>Verma A, Jiang CY, Betts TR, Chen J, Deisenhofer I, Mantovan R, Macle L, Morillo CA, Haverkamp W, Weerasooriya R, Albenque JP, Nardi S, Menardi E, Novak P, Sanders P; STAR AF II Investigators. Approaches to catheter ablation for persistent atrial fibrillation. N Engl J Med. 2015 May 7;372(19):1812-22. doi: 10.1056/NEJMoa1408288.</citation>
    <PMID>25946280</PMID>
  </reference>
  <reference>
    <citation>Irie T, Yu R, Bradfield JS, Vaseghi M, Buch EF, Ajijola O, Macias C, Fujimura O, Mandapati R, Boyle NG, Shivkumar K, Tung R. Relationship between sinus rhythm late activation zones and critical sites for scar-related ventricular tachycardia: systematic analysis of isochronal late activation mapping. Circ Arrhythm Electrophysiol. 2015 Apr;8(2):390-9. doi: 10.1161/CIRCEP.114.002637. Epub 2015 Mar 4.</citation>
    <PMID>25740836</PMID>
  </reference>
  <reference>
    <citation>Anter E, McElderry TH, Contreras-Valdes FM, Li J, Tung P, Leshem E, Haffajee CI, Nakagawa H, Josephson ME. Evaluation of a novel high-resolution mapping technology for ablation of recurrent scar-related atrial tachycardias. Heart Rhythm. 2016 Oct;13(10):2048-55. doi: 10.1016/j.hrthm.2016.05.029. Epub 2016 Jun 1.</citation>
    <PMID>27262767</PMID>
  </reference>
  <reference>
    <citation>Viswanathan K, Mantziari L, Butcher C, Hodkinson E, Lim E, Khan H, Panikker S, Haldar S, Jarman JW, Jones DG, Hussain W, Foran JP, Markides V, Wong T. Evaluation of a novel high-resolution mapping system for catheter ablation of ventricular arrhythmias. Heart Rhythm. 2017 Feb;14(2):176-183. doi: 10.1016/j.hrthm.2016.11.018. Epub 2016 Nov 17.</citation>
    <PMID>27867071</PMID>
  </reference>
  <reference>
    <citation>Luther V, Sikkel M, Bennett N, Guerrero F, Leong K, Qureshi N, Ng FS, Hayat SA, Sohaib SM, Malcolme-Lawes L, Lim E, Wright I, Koa-Wing M, Lefroy DC, Linton NW, Whinnett Z, Kanagaratnam P, Davies DW, Peters NS, Lim PB. Visualizing Localized Reentry With Ultra-High Density Mapping in Iatrogenic Atrial Tachycardia: Beware Pseudo-Reentry. Circ Arrhythm Electrophysiol. 2017 Apr;10(4). pii: e004724. doi: 10.1161/CIRCEP.116.004724.</citation>
    <PMID>28356307</PMID>
  </reference>
  <reference>
    <citation>Ciaccio EJ, Chow AW, Davies DW, Wit AL, Peters NS. Localization of the isthmus in reentrant circuits by analysis of electrograms derived from clinical noncontact mapping during sinus rhythm and ventricular tachycardia. J Cardiovasc Electrophysiol. 2004 Jan;15(1):27-36.</citation>
    <PMID>15028069</PMID>
  </reference>
  <reference>
    <citation>Anter E, Tschabrunn CM, Contreras-Valdes FM, Li J, Josephson ME. Pulmonary vein isolation using the Rhythmia mapping system: Verification of intracardiac signals using the Orion mini-basket catheter. Heart Rhythm. 2015 Sep;12(9):1927-34. doi: 10.1016/j.hrthm.2015.05.019. Epub 2015 May 19.</citation>
    <PMID>26001505</PMID>
  </reference>
  <reference>
    <citation>Wann LS, Curtis AB, January CT, Ellenbogen KA, Lowe JE, Estes NA 3rd, Page RL, Ezekowitz MD, Slotwiner DJ, Jackman WM, Stevenson WG, Tracy CM; 2011 Writing Group Members, Fuster V, Ryd√©n LE, Cannom DS, Le Heuzey JY, Crijns HJ, Lowe JE, Curtis AB, Olsson S, Ellenbogen KA, Prystowsky EN, Halperin JL, Tamargo JL, Kay GN, Wann L; 2006 Writing Committee Members, Jacobs AK, Anderson JL, Albert N, Hochman JS, Buller CE, Kushner FG, Creager MA, Ohman EM, Ettinger SM, Stevenson WG, Guyton RA, Tarkington LG, Halperin JL, Yancy CW; ACCF/AHA Task Force Members. 2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (updating the 2006 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2011 Jan 4;123(1):104-23. doi: 10.1161/CIR.0b013e3181fa3cf4. Epub 2010 Dec 20. Erratum in: Circulation. 2011 Aug 2;124(5):e173.</citation>
    <PMID>21173346</PMID>
  </reference>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>November 5, 2018</study_first_submitted>
  <study_first_submitted_qc>November 8, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">November 13, 2018</study_first_posted>
  <last_update_submitted>February 7, 2020</last_update_submitted>
  <last_update_submitted_qc>February 7, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 11, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Paroxysmal</keyword>
  <keyword>Atrial</keyword>
  <keyword>Fibrillation</keyword>
  <keyword>Ventricular</keyword>
  <keyword>Tachycardia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atrial Fibrillation</mesh_term>
    <mesh_term>Atrial Flutter</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

